Literature DB >> 26914913

Managing an Unprovoked First Seizure in Adults.

David S Gloss1, Allan Krumholz2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26914913     DOI: 10.1007/s40263-016-0321-z

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  22 in total

1.  Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  Allan Krumholz; Samuel Wiebe; Gary S Gronseth; David S Gloss; Ana M Sanchez; Arif A Kabir; Aisha T Liferidge; Justin P Martello; Andres M Kanner; Shlomo Shinnar; Jennifer L Hopp; Jacqueline A French
Journal:  Neurology       Date:  2015-04-21       Impact factor: 9.910

2.  Quality improvement in neurology: Epilepsy Update Quality Measurement Set.

Authors:  Nathan B Fountain; Paul C Van Ness; Amy Bennett; John Absher; Anup D Patel; Kevin N Sheth; David S Gloss; Diego A Morita; Mona Stecker
Journal:  Neurology       Date:  2015-04-07       Impact factor: 9.910

Review 3.  Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review.

Authors:  Laura J Bonnett; Arif Shukralla; Catrin Tudur-Smith; Paula R Williamson; Antony G Marson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-01-13       Impact factor: 10.154

4.  Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.

Authors:  A Marson; A Jacoby; A Johnson; L Kim; C Gamble; D Chadwick
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 79.321

5.  Risk of recurrent seizures after two unprovoked seizures.

Authors:  W A Hauser; S S Rich; J R Lee; J F Annegers; V E Anderson
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 6.  Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J A French; A M Kanner; J Bautista; B Abou-Khalil; T Browne; C L Harden; W H Theodore; C Bazil; J Stern; S C Schachter; D Bergen; D Hirtz; G D Montouris; M Nespeca; B Gidal; W J Marks; W R Turk; J H Fischer; B Bourgeois; A Wilner; R E Faught; R C Sachdeo; A Beydoun; T A Glauser
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

7.  First seizure in adults: to treat or not to treat.

Authors:  B Chandra
Journal:  Clin Neurol Neurosurg       Date:  1992       Impact factor: 1.876

8.  Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures.

Authors:  A Jacoby; C Gamble; J Doughty; A Marson; D Chadwick
Journal:  Neurology       Date:  2007-04-10       Impact factor: 9.910

Review 9.  First seizure definitions and worldwide incidence and mortality.

Authors:  W Allen Hauser; Ettore Beghi
Journal:  Epilepsia       Date:  2008       Impact factor: 5.864

10.  Adverse antiepileptic drug effects in new-onset seizures: a case-control study.

Authors:  P Perucca; A Jacoby; A G Marson; G A Baker; S Lane; E K T Benn; D J Thurman; W A Hauser; F G Gilliam; D C Hesdorffer
Journal:  Neurology       Date:  2011-01-18       Impact factor: 9.910

View more
  1 in total

1.  Characteristics of the patients who admitted to the emergency department with seizures and the factors affecting the frequency of admission.

Authors:  Gülten Bozali; Ataman Kose; Seyran B Babus; Sükrü H Kaleağası; Gülhan O Temel
Journal:  Neurosciences (Riyadh)       Date:  2021-04       Impact factor: 0.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.